PrEsentation
Pharmaceutical Contract Manufacturing Organisation (CMO)
Management
Xavier Castelli, CEO
Sébastien Aguettant, Managing Director
Investment date
April 2004
June 2007
Investment Type
MBO, spin-off (Laboratoire Aguettant), build-up
Activa Capital's role
Majority shareholder
Turnover 2007
€94M
Location
Tours, Brétigny-sur-Orge, Evreux, Lille - 550 employees
Project
Reinforce Delpharm's leading position in the French market through the acquisition of other CMOs in France and Europe.
Build-up
In May 2006, Delpharm acquired from Schering its French manufacturing plant based in Lille. In 2005, this unit realised sales of €36m.
Exit
In June 2007, Activa Capital exited Delpharm. The management team has acquired a majority stake in Delpharm.
